razoxane has been researched along with Endothelioma, Vascular in 1 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 1 (100.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Boehler, F; Breitfellner, G; Eiter, H; Fritzsche, H; Rhomberg, W | 1 |
1 other study(ies) available for razoxane and Endothelioma, Vascular
| Article | Year |
|---|---|
Treatment options for malignant hemangioendotheliomas of the thyroid.
Topics: Aged; Aged, 80 and over; Antineoplastic Agents; Combined Modality Therapy; Female; Hemangioendothelioma; Humans; Male; Middle Aged; Radiation-Sensitizing Agents; Razoxane; Survival Analysis; Thyroid Neoplasms | 2004 |